1
|
Marín MC, Elizalde J, Villagómez A, Cerón U, Poblano M, Palma-Lara I, Sánchez JR, Monares E, Arellano A, Muriel A, Peñuelas Ó, Frutos-Vivar F, Esteban A. Have there been changes in the application of mechanical ventilation in relation to scientific evidence? A multicenter observational study in Mexico. Med Intensiva 2019; 44:333-343. [PMID: 31130359 DOI: 10.1016/j.medin.2019.03.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Revised: 03/16/2019] [Accepted: 03/18/2019] [Indexed: 10/26/2022]
Abstract
OBJECTIVE The main study objectives were to describe the practice of mechanical ventilation over an 18-year period in Mexico, and estimate changes in mortality among critical patients subjected to invasive mechanical ventilation (IMV). DESIGN A retrospective subanalysis of a prospective observational study conducted in 1998, 2004, 2010 and 2016 was carried out. SETTING Intensive Care Units (ICUs) in Mexico. PARTICIPANTS Adult patients consecutively enrolled in the ICU during one month and who underwent IMV for more than 12hours or noninvasive mechanical ventilation for more than one hour. Follow-up was performed up to a maximum of 28 days after inclusion. INTERVENTIONS None. PRINCIPAL VARIABLES OF INTEREST Age, sex, severity upon admission as estimated by SAPS II, parameters of daily arterial blood gases, treatment and complication variables, date and status at discharge from the ICU and from hospital. RESULTS A total of 959 patients were included in 81 ICUs. Tidal volume (vt) decreased significantly both in patients with acute respiratory distress syndrome (ARDS) criteria (estimated 8.5ml/kg b.w. in 1998 to 6ml/kg in 2016; P<0.001) and in patients without ARDS (estimated 9ml/kg b.w. in 1998 to 6ml/kg in 2016; P<0.001). The ventilatory protective strategy (defined as vt < 6ml/kg or < 8ml/kg and a plateau pressure < 30cmH2O) was: 19% in 1998, 44% in 2004, 58% in 2010 and 75% in 2016 (P<0.001). The adjusted mortality rate in ICU over the 4 periods was: in 2004, odds ratio (OR) 1.05 (95% confidence interval, 95%CI: 0.73-1.72; P=0.764); in 2010, OR 1.68 (95%CI: 1.13-2.48; P=0.009); in 2016, OR 0.85 (95%CI: 0.60-1.20; P=0.368). CONCLUSIONS The clinical practice of IMV in Mexican ICUs has been modified over a period of 18 years. The most significant change is the ventilatory strategy based on low vt. These changes have not been associated with significant changes in mortality.
Collapse
Affiliation(s)
- M C Marín
- Unidad de Cuidados Intensivos, Hospital Regional 1.° de Octubre, ISSSTE, Ciudad de México, México; Unidad de Cuidados Intensivos, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
| | - J Elizalde
- Unidad de Cuidados Intensivos, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
| | - A Villagómez
- Unidad de Cuidados Intensivos, Hospital Regional 1.° de Octubre, ISSSTE, Ciudad de México, México
| | - U Cerón
- Unidad de Cuidados Intensivos, Hospital Español de México, Ciudad de México, México
| | - M Poblano
- Unidad de Cuidados Intensivos, Hospital H+ Querétaro, Ciudad de México, México
| | - I Palma-Lara
- Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México
| | - J R Sánchez
- Unidad de Cuidados Intensivos, Hospital Regional de PEMEX, Ciudad Madero (Tamaulipas), México
| | - E Monares
- Unidad de Cuidados Intensivos, Hospital San Ángel Inn Universidad, Ciudad de México, México
| | - A Arellano
- Unidad de Cuidados Intensivos, Hospital Regional de Alta Especialidad Ixtapaluca, SSA, Ixtapaluca (Estado de México)
| | - A Muriel
- Unidad de Bioestadística, Hospital Universitario Ramón y Cajal, CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, España
| | - Ó Peñuelas
- Unidad de Cuidados Intensivos y Grandes Quemados, Hospital Universitario de Getafe, CIBER de Enfermedades Respiratorias, Getafe (Madrid), España.
| | - F Frutos-Vivar
- Unidad de Cuidados Intensivos y Grandes Quemados, Hospital Universitario de Getafe, CIBER de Enfermedades Respiratorias, Getafe (Madrid), España
| | - A Esteban
- Unidad de Cuidados Intensivos y Grandes Quemados, Hospital Universitario de Getafe, CIBER de Enfermedades Respiratorias, Getafe (Madrid), España
| | | | | | | | | |
Collapse
|
2
|
Tapia E, Sánchez-Lozada LG, García-Niño WR, García E, Cerecedo A, García-Arroyo FE, Osorio H, Arellano A, Cristóbal-García M, Loredo ML, Molina-Jijón E, Hernández-Damián J, Negrette-Guzmán M, Zazueta C, Huerta-Yepez S, Reyes JL, Madero M, Pedraza-Chaverrí J. Curcumin prevents maleate-induced nephrotoxicity: relation to hemodynamic alterations, oxidative stress, mitochondrial oxygen consumption and activity of respiratory complex I. Free Radic Res 2014; 48:1342-54. [PMID: 25119790 DOI: 10.3109/10715762.2014.954109] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The potential protective effect of the dietary antioxidant curcumin (120 mg/Kg/day for 6 days) against the renal injury induced by maleate was evaluated. Tubular proteinuria and oxidative stress were induced by a single injection of maleate (400 mg/kg) in rats. Maleate-induced renal injury included increase in renal vascular resistance and in the urinary excretion of total protein, glucose, sodium, neutrophil gelatinase-associated lipocalin (NGAL) and N-acetyl β-D-glucosaminidase (NAG), upregulation of kidney injury molecule (KIM)-1, decrease in renal blood flow and claudin-2 expression besides of necrosis and apoptosis of tubular cells on 24 h. Oxidative stress was determined by measuring the oxidation of lipids and proteins and diminution in renal Nrf2 levels. Studies were also conducted in renal epithelial LLC-PK1 cells and in mitochondria isolated from kidneys of all the experimental groups. Maleate induced cell damage and reactive oxygen species (ROS) production in LLC-PK1 cells in culture. In addition, maleate treatment reduced oxygen consumption in ADP-stimulated mitochondria and diminished respiratory control index when using malate/glutamate as substrate. The activities of both complex I and aconitase were also diminished. All the above-described alterations were prevented by curcumin. It is concluded that curcumin is able to attenuate in vivo maleate-induced nephropathy and in vitro cell damage. The in vivo protection was associated to the prevention of oxidative stress and preservation of mitochondrial oxygen consumption and activity of respiratory complex I, and the in vitro protection was associated to the prevention of ROS production.
Collapse
Affiliation(s)
- E Tapia
- Department of Nephrology, National Institute of Cardiology I. Ch. , Mexico City , Mexico
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Chajchir A, Benzaquen I, Arellano A, Spagnuolo N. Injerto de grasa y Ritidectomía. Cir plást iberolatinoam 2013. [DOI: 10.4321/s0376-78922013000500022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
4
|
Mañes A, Jové J, Ballester R, Tuset V, Caro M, Planas I, Manzano J, Boada A, Arellano A. EP-1248 HYPOFRACTIONATED RADIOTHERAPY AFTER LYMPHADENECTOMY FOR NODAL INVOLVEMENT OF MALIGNANT MELANOMA. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71581-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
5
|
Jove J, Arellano A, Ballester R, Tuset V, Caro M, Luguera E, Planas I, Mañes A, Villà S, Moretones C, Melero A, Molero J, Antón JA. Use of 8-Gy radiotherapy fractions for the treatment of lung cancer in fragile patients. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e17504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6
|
Rahimian J, Girvigian M, Feng L, Chen J, Miller M, Arellano A, Lodin K. Frameless Stereotactic Radiosurgery of Arteriovenous Malformations using High Resolution 3D Rotational Angiograms, and Novalis ExacTrac Systems. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.1792] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
7
|
Girvigian M, Han J, Cahan B, Chen J, Arellano A, Miller M, Lodin K, Rahimian J. Early Outcomes of Basal Meningiomas Treated with Image-guided Hypofractionated Stereotactic Radiotherapy. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
8
|
Garcia AM, Villà S, Balañàa C, Teixidor P, Puyalto P, García-Armengol R, Carrato C, Sanz C, Domènech S, Arellano A. 8717 Short course of hypofractionated radiotherapy and concomitant temozolomide in patients affected with glioblastoma with V-VI prognostic classes – a pilot study. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71691-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
Balaña C, Capellades J, Teixidor P, Roussos I, Ballester R, Cuello M, Arellano A, Florensa R, Rosell R. Clinical course of high-grade glioma patients with a "biopsy-only" surgical approach: a need for individualised treatment. Clin Transl Oncol 2008; 9:797-803. [PMID: 18158984 DOI: 10.1007/s12094-007-0142-0] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
INTRODUCTION 'Biopsy-only' high-grade glioma (HGG) patients get limited benefit from post-operative treatments, and as a group, negatively impact median survival outcomes. MATERIAL AND METHODS We retrospectively evaluated clinical characteristics, treatment and overall survival of HGG patients with a 'biopsy- only' surgical approach diagnosed between 1997 and 2005 at a University Hospital in Spain. RESULTS In 31% of 294 suspected gliomas, only a diagnostic biopsy was undertaken. Reasons for 'biopsy-only' for all patients were either location in eloquent areas: (motor area 18.7%, language area 25,3%, basal ganglia 7.7%, visual area 4.4%) or extension of the disease (corpus callosum invasion 14.3% and multicentricity/multifocality 28.6%). Seventy-four patients (80.4%) were HGG: 26% of all grade IV and 49% of all grade III tumours. For these patients, post-operative Karnofsky Performance Status of over 70%, median age and median survival were, respectively: 64 and 70%, 60.7 and 57 years old, and 23.1 and 42.7 weeks (p=0.0006). Patients lived longer if post-operative treatment was given, in all grades (p<0.0001). Nineteen patients (25.6%) died within 42 days after surgery. Only 60% of them initiated radiotherapy and 10% of them did not complete it. However, tumour grade, radiotherapy and temozolomide- based chemotherapy were independently associated with longer survival in multivariate analysis (p<0.05). CONCLUSION Almost one third of HGG patients can undergo only a biopsy and not debulking surgery. Although radiotherapy improves survival, only 50% of them complete the treatment. An individualised approach to these patients is needed to facilitate a correct analysis of therapy results. New therapies must be investigated in these patients.
Collapse
Affiliation(s)
- C Balaña
- Medical Oncology Service, Institut Català d'Oncologia, Germans Trias i Pujol, Badalona, Barcelona, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Bian H, Chin M, Kawa SR, Duncan B, Arellano A, Kasibhatla P. Sensitivity of global CO simulations to uncertainties in biomass burning sources. ACTA ACUST UNITED AC 2007. [DOI: 10.1029/2006jd008376] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
11
|
Garrido P, Massuti B, Jimenez A, Samper P, Mesia C, Rodriguez N, Lianes P, Arellano A, Ramos A, Rosell R. 6500 ORAL Randomized phase II trial using concomitant chemoradiation plus induction (I) or consolidation (C) chemotherapy (CT) for unresectable stage III non-small cell lung cancer (NSCLC) patients (pts). Mature results of the SLCG 0008 study. EJC Suppl 2007. [DOI: 10.1016/s1359-6349(07)71328-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
12
|
Font A, Arellano A, Fernández-Llamazares J, Casas D, Boix J, Cardenal J, Margelí M, Manzano JL, Abad A, Rosell R. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer. Clin Transl Oncol 2007; 9:177-82. [PMID: 17403629 DOI: 10.1007/s12094-007-0032-5] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
INTRODUCTION To evaluate the efficacy and tolerability of weekly docetaxel concurrent with radiotherapy in inoperable oesophageal cancer patients. MATERIAL AND METHODS Thirty-four oesophageal cancer patients with co-morbid medical conditions, locally advanced tumours (T4) or advanced age (older than 75 years) received docetaxel (20 mg/m2 weekly) plus concurrent radiotherapy (2 Gy daily, to a total dose of 66 Gy). Twenty-two patients (64%) were stage III, 19 of whom had T4 tumours. RESULTS Twenty-seven patients (79%) completed the planned chemoradiotherapy treatment. Nine patients (26%) achieved a complete response and 8 (24%) achieved a partial response, for an overall response rate of 50%. Median survival was 6 months, and 1-year survival was 35%. Patients with T4 tumours had significantly shorter survival than other patients: 5 months for T4 tumours vs. 11 months for T1-3 (p=0.04). Grade 3-4 oesophagitis occurred in 6 patients (17%). There were two treatment-related deaths due to radiation pneumonitis. CONCLUSIONS Docetaxel plus concurrent radiotherapy is active in poor-prognosis oesophageal cancer patients, with a lower incidence of severe oesophagitis than with cisplatin-based chemoradiotherapy regimens. This schedule can be considered, especially in patients with non-T4 tumours who are not candidates for oesophageal resection.
Collapse
Affiliation(s)
- A Font
- Medical Oncology Service, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Garrido P, Resell R, Arellano A, Ramos A, Massuti T, Andreu J, Cardenal F, Arnaiz A, Amador M, Alberola V. PD-042 Induction (I) or consolidation (C) chemotherapy withdocetaxel (D) and gemcitabine (G) plus concomitant chemoradiotherapy (CT/TRT) with docetaxel and carboplatin (Cb) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Initial report of the randomized phase II trial SLCG 0008. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80375-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Garrido P, Massutí B, Cardenal F, Moran T, Alberola V, Maeztu I, Dómine M, Isla D, Arellano A, Ramos A. Induction (I) or consolidation (C) chemotherapy with docetaxel (D) and gemcitabine (G) plus concomitant chemoradiotherapy (CT/TRT) with docetaxel and carboplatin (Cb) for unresectable stage III non-small cell lung cancer (NSCLC) patients (p). Initial report of the randomized phase II trial SLCG 0008. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- P. Garrido
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - B. Massutí
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - F. Cardenal
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - T. Moran
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - V. Alberola
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - I. Maeztu
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - M. Dómine
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - D. Isla
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - A. Arellano
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| | - A. Ramos
- Hosp Ramon y Cajal, Madrid, Spain; Hosp Alicante, Alicante, Spain; ICO, Barcelona, Spain; Hosp Germans Trias i Pujol, Badalona, Barcelona, Spain; Hosp Arnau Vilanova, Valencia, Spain; Hosp Virgen de los Lirios, Alcoy, Alicante, Spain; Fundación Jimenez Díaz, Madrid, Spain; Hosp Clínico, Zaragoza, Spain
| |
Collapse
|
15
|
Vallejos V, Balaña C, Fraile M, Roussos Y, Capellades J, Cuadras P, Ballester R, Ley A, Arellano A, Rosell R. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas. J Neurooncol 2002; 59:81-90. [PMID: 12222842 DOI: 10.1023/a:1016389119399] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
PURPOSE To assess the potential role of 201Tl single photon emission tomography (201-Thallium SPECT) when compared to other imaging modalities in the evaluation of the response to therapy in high grade gliomas. MATERIALS AND METHODS Twenty patients with histologically proved high grade glioma have been included: 15 with glioblastoma (GBM), 3 with anaplastic astrocytoma (AA) and 2 with anaplastic oligoastrocytoma (AOA). Patients were assessed by 201Tl SPECT, computed tomography (CT) and magnetic resonance imaging (MRI) at (a) either at the moment of maximum response to first line chemotherapy, or after the completion of radiotherapy and chemotherapy if post-surgical residual disease was present, and (b) after the completion of second line chemotherapy if disease persisted, or either a relapse or disease progression was confirmed. Final response was evaluated according to the McDonald criteria, and by comparing SPECT, CT and MRI results. RESULTS According to the McDonald criteria, clinical response after first line chemotherapy was 5 partial response, 7 stable disease and 8 progressive disease. Evaluation by 201Tl SPECT was in agreement with such criteria in nearly all patients (90%). MRI findings closely agreed with the clinical follow-up. CT findings clearly differed from those observed by SPECT and MRI. After second line therapy, 10 patients progressed, 3 had stable disease and 7 had partial response. 201Tl SPECT agreed with the clinical status in 89% cases, whereas MRI and, specially CT, fared significantly lower. CONCLUSION Compared to conventional neuroimaging, 201Tl SPECT added valuable information in the assessment of the response to therapy in our patient population; whenever findings were not conclusive and in the case of disagreement between CT and MRI findings.
Collapse
Affiliation(s)
- V Vallejos
- Department of Nuclear Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Larrucea E, Arellano A, Santoyo S, Ygartua P. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur J Pharm Biopharm 2001; 52:113-9. [PMID: 11522475 DOI: 10.1016/s0939-6411(01)00158-8] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
The influence of oleic acid (OA) on the in vitro percutaneous absorption of tenoxicam (TEN) and its combined effect with propylene glycol (PG) was studied using Franz-type diffusion cells. Furthermore, at defined concentrations of OA, complexes of the drug with cyclodextrins (MbetaCD and gammaCD) were added because their combined use may be an interesting approach to raise TEN flux. In addition, the amount of TEN retained in the skin after topical administration of several formulations was determined. It was found that OA content markedly increased TEN absorption when compared to the control gel; the highest drug flux was obtained by 15% of OA. The absorption rate of TEN increased in parallel with increasing OA concentration, due to the alteration of the stratum corneum caused by this enhancer. Moreover, the action of OA is likely to be strongly dependent on the vehicle used since drug penetration tended to increase with increasing PG content in the vehicle, especially at the high OA concentrations. Contrary to our expectations, addition of CD complexes did not produce a significant further enhancement. Skin pretreatment with OA, independently of the vehicle used to dissolve the fatty acid, dramatically improved TEN percutaneous penetration. The amount of TEN retained in the skin was related to the flux values obtained with each formulation.
Collapse
Affiliation(s)
- E Larrucea
- Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Navarra, 31080 Pamplona, Spain.
| | | | | | | |
Collapse
|
17
|
Larrucea E, Arellano A, Santoyo S, Ygartua P. Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug. Drug Dev Ind Pharm 2001; 27:251-60. [PMID: 11291205 DOI: 10.1081/ddc-100000243] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Solid complexes of tenoxicam (TEN) with cyclodextrins (CDs), in a 1:1 molar ratio, were obtained by the coprecipitation method and characterized by x-ray diffractometry, infrared spectroscopy, and differential scanning calorimetry. The binding capacity of the CDs with TEN was also demonstrated in aqueous solution and in water-propylene glycol mixtures. The purpose of this study was to determine the effect of CDs on the in vitro percutaneous penetration of TEN from carbopol gels, taking into account the role of the CD cavity size and the nature of the substituents. The effect of pretreatment was studied too. In vitro permeation experiments were carried out on Franz diffusion cells using cellulose nitrate membranes and abdominal rat skin. In these results, the release rates of the drug scarcely decreased when the CDs were added, probably because of a lower concentration of the free drug and an increased gel viscosity. However, it was also found that CDs, particularly gamma-CD and M-beta-CD, can improve slightly TEN absorption through the skin. Pretreatment studies with CDs, however, provided no effects on TEN permeation, but lag time was markedly reduced, suggesting a faster partitioning of TEN into the skin. Therefore, the use of pretreatment with CDs would be interesting when a quick action of the drug is desired.
Collapse
Affiliation(s)
- E Larrucea
- Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Navarra, 31080 Pamplona, Spain.
| | | | | | | |
Collapse
|
18
|
Ge J, Arellano A, Salz J. Surgical correction of hyperopia: clear lens extraction and laser correction. Ophthalmol Clin North Am 2001; 14:301-13, viii. [PMID: 11406426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
Modern ophthalmology offers a series of surgical procedures to correct a wide range of hyperopia and hyperopic astigmatism. Varies excimer lasers and thermal lasers have been proven safe and effective. Phakic implants and clear lens extraction offers alternatives for moderate to high hyperopic patients. Indications, techniques, and clinical study results were reviewed and summarized.
Collapse
Affiliation(s)
- J Ge
- Laser Vision Medical Associates, Los Angeles, California, USA
| | | | | |
Collapse
|
19
|
Iglesia MA, Puig J, Arellano A, Bueno J. Oral manifestations associated with elastic pseudoxanthoma. Med Oral 2000; 5:261-265. [PMID: 11507563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
20
|
Font A, Guillot M, Fernandez-Llamazares J, Arellano A, Boix J, Casas D, Abad A, Rosell R. Preoperative chemotherapy with weekly cisplatin plus continous infusion of fluorouracil and hyperfractionated radiation for esophageal cancer. Eur J Cancer 1999. [DOI: 10.1016/s0959-8049(99)80967-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
21
|
Arellano A, Santoyo S, Martín C, Ygartua P. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. Eur J Pharm Sci 1999; 7:129-35. [PMID: 9845796 DOI: 10.1016/s0928-0987(98)00010-4] [Citation(s) in RCA: 87] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The influence of propylene glycol (PG) on the in vitro penetration of diclofenac sodium (DFS) through a synthetic membrane and abdominal rat skin from carbopol gels was investigated using Franz-type diffusion cells. The combined effect of isopropyl myristate (IPM) and PG was also evaluated. It was found that the penetration through the synthetic membrane was well described by the Higuchi model. The gel containing 40% PG showed the highest release rate, indicating that a releasing maximum exists for PG content which provides the fully solubilized drug in the vehicle. When using rat skin as the barrier, the penetration rate was controlled by the membrane. DFS flux decreased with increasing PG content of the gels due to an increase of the drug affinity to the vehicle. A cosolvent action of PG was evident. However, the combination of PG and IPM resulted in a synergistic enhancement of DFS flux. Maximum enhancing activity was obtained from gels containing 40% PG, which yielded an enhancement ratio of about 8. Increasing IPM content from 3 to 5% increased the flux and decreased the lag time taken to reach a steady-state level.
Collapse
Affiliation(s)
- A Arellano
- Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Navarra, Apdo. 177. 31080, Pamplona, Spain.
| | | | | | | |
Collapse
|
22
|
Arellano A, Santoyo S, Martn C, Ygartua P. Surfactant effects on the in vitro percutaneous absorption of diclofenac sodium. Eur J Drug Metab Pharmacokinet 1998; 23:307-12. [PMID: 9725498 DOI: 10.1007/bf03189356] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Nonionic surfactants, which are a safe class of enhancers, may offer means of enhancing drug permeation through the skin. In order to determine this effect, the influence of four nonionic surfactants on the percutaneous absorption of diclofenac sodium from carbopol gels containing 40% propylene glycol was investigated. In vitro diffusion experiments were carried out using excised full-thickness abdominal rat skin as well as cellulose nitrate membranes. The data of this study clearly revealed that Tween 80 decreased diclofenac penetration rate. This was due to a decrease in thermodynamic activity as a result of micellar complexation. In contrast, the more hydrophobic sorbitans enhanced diclofenac skin penetration, probably due to changes in the barrier properties of the skin and in the vehicle-stratum corneum partition coefficient. The most enhancing effect was induced by Span 20, a surfactant with a C12 saturated hydrophobic group. However, diffusional lag times for all the tested surfactants were longer than for the control gel.
Collapse
Affiliation(s)
- A Arellano
- Departamento de Farmacia y Tecnologia Farmacéutica, Facultad de Farmacia, Universidad de Navarra, Pamplona, Spain
| | | | | | | |
Collapse
|
23
|
Vela D, Ribera JM, Florensa R, Arellano A, Vaquero M, Batlle M, Flores A, Millá F, Feliu E. [Spinal cord compression in non-Hodgkin's lymphoma. A study of 10 patients]. Med Clin (Barc) 1997; 109:375-7. [PMID: 9379720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Spinal cord compression is an infrequent event in patients with non-Hodgkin's lymphomas (NHL) and early diagnosis and therapy are required. The main clinical and histologic characteristics as well as the response to therapy in 10 NHL patients with spinal cord compression diagnosed at a single center in a 7-year period are referred. The main initial clinical manifestations were pain in dorsal or lumbar regions (5 cases) and paraparesia or paraplegia (5 patients). Infection by human immunodeficiency virus (HIV) was present in four cases. In 8 patients spinal cord compression was the initial manifestation of NHL. Pathologic diagnosis showed intermediate or high-grade lymphoma in 8 out of 10 cases and immunologic phenotype was B-cell in all cases. Laminectomy followed by radiation therapy and chemotherapy was performed in 4 cases, radiotherapy and chemotherapy in two, isolated chemotherapy in 3 and radiation therapy was administered to the remaining case. Complete response was observed in 4 cases and 6 cases were resistant to treatment. No patient with HIV infection responded to treatment. Six patients had died, median survival time for the whole series being 4 months, and the actuarial probability of survival was 40% at the first year.
Collapse
Affiliation(s)
- D Vela
- Servicio de Hematología, Hospital Universitario Germans Trias i Pujol, Universidad Autónoma de Barcelona
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Santoyo S, Arellano A, Ygartua P, Martín C. In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin. Pharm Acta Helv 1996; 71:141-6. [PMID: 8810580 DOI: 10.1016/0031-6865(96)00004-0] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The in vitro release of piroxicam from carbomer gels and its penetration through isopropyl myristate impregnated membranes and abdominal rat skin were investigated. Attempts were made to relate the differences in the release rate with physicochemical properties of the drug and the vehicle. The results showed that piroxicam is released from the topical gel formulations and diffuses through skin. It is suggested that although piroxicam flux across abdominal rat skin was lower than through isopropyl myristate membranes, this kind of membranes can be used in preliminary screening among the different piroxicam formulations.
Collapse
Affiliation(s)
- S Santoyo
- Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Navarra, Pamplona, Spain
| | | | | | | |
Collapse
|
25
|
Abstract
Induction (neoadjuvant) chemotherapy has become an accepted treatment for stage IIIA (T1-3N2M0) non-small cell lung cancer. In two recent randomized trials, neoadjuvant chemotherapy plus surgery gave an increase in median survival at least fivefold greater than surgery alone. The Spanish Lung Cancer Group trial of preoperative chemotherapy, in which the cisplatin dose was randomized to either 50 mg/m2 or 100 mg/m2 plus 3 g/m2 ifosfamide and 6 mg/m2 mitomycin, examines the effect of K-ras gene mutations on tumor response and survival. Patients whose tumors contain K-ras gene mutations are more likely to develop distant metastases and have lower median survival than patients without such mutations. Microsatellite instability seems to be a frequent mechanism of genetic aberrations. Knowledge about these genetic alterations could have prognostic importance and may identify the patients who should receive the most aggressive additional treatment.
Collapse
Affiliation(s)
- R Rosell
- Medical Oncology Service, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
| | | | | | | | | | | | | |
Collapse
|
26
|
Carron JA, Bates RC, Smith AI, Tetoz T, Arellano A, Gordon DL, Burns GF. Factor H co-purifies with thrombospondin isolated from platelet secretate. Biochim Biophys Acta 1996; 1289:305-11. [PMID: 8620012 DOI: 10.1016/0304-4165(95)00095-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Thrombospondin is a trimeric glycoprotein that has several known functions, including roles in platelet aggregation, phagocytosis and an inhibitor of angiogenesis. Typically the molecule is isolated from platelet secretate by heparin affinity followed by sizing chromatography. In this study, purity is analysed by 7.5% SDS-PAGE under reducing conditions when thrombospondin monomers run as a band at around 180 kDa. Under nonreducing conditions of 7.5% SDS-PAGE, thrombospondin does not penetrate beyond the stacking gel; however, under these conditions a major contaminating band can be seen which, upon reduction, merges into the thrombospondin band. Further purification of this contaminating protein was achieved by DEAE chromatography and it was identified as Factor H by peptide sequencing and immunoblotting. Factor H function was demonstrated by the ability of the protein to function as a cofactor in the Factor-I-mediated cleavage of C3b. Since Factor H has several known functions, such contamination could confound functional studies of thrombospondin thus purified and a pre-elution step of the heparin affinity column is recommended.
Collapse
Affiliation(s)
- J A Carron
- Cancer Research Unit, Faculty of Medicine, University of Newcastle, Royal Newcastle Hospital, NSW, Australia
| | | | | | | | | | | | | |
Collapse
|
27
|
Arellano A, Pérez M, López-Osuna L, Velázquez J, Granados J, Justiniani N, Santos J, Madrazo A, Muñoz L, Krestschmer R. Increased frequency of HLA-DR3 and complotype SC01 in mexican mestizo children with amebic abscess of the liver (AAL). Hum Immunol 1996. [DOI: 10.1016/0198-8859(96)85367-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
28
|
|
29
|
Arellano A, Cadenal J, Melero A, Castel A, Ballester R, Tuset V. 432 Matching half beams in head and neck radiotherapy. planning and dosimetry. Eur J Cancer 1995. [DOI: 10.1016/0959-8049(95)95685-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
30
|
Santoyo S, Arellano A, Ygartua P, Martin C. Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int J Pharm 1995. [DOI: 10.1016/0378-5173(94)00344-5] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
31
|
Gordon DL, Papazaharoudakis H, Sadlon TA, Arellano A, Okada N. Upregulation of human neutrophil CD59, a regulator of the membrane attack complex of complement, following cell activation. Immunol Cell Biol 1994; 72:222-9. [PMID: 7522216 DOI: 10.1038/icb.1994.33] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
CD59 is a membrane glycoprotein that regulates the membrane attack complex of complement and protects cells from autologous complement damage. Human polymorphonuclear leucocyte (PMN) expression of CD59 was confirmed by flow cytometry following staining with mAb 1F5, and western blotting revealed staining of a 19-23 kDa band. Warming of PMN from 4 to 37 degrees C resulted in spontaneous CD59 upregulation. A dose-dependent increase in expression following PMN stimulation with FMLP was observed and occurred within minutes, indicating that new protein synthesis was not required. Treatment of PMN with calcium ionophore A23187 resulted in similar increases in CD59 expression. This occurred in the presence or absence of extracellular calcium, indicating that upregulation was dependent on release of calcium from intracellular stores. Evidence for a mobilizable intracellular pool of CD59 was obtained by detection of increased binding of 1F5 following PMN permeabilization; CD59 could also be re-expressed after stripping by phosphatidylinositol specific phospholipase C (PI-PLC) by treatment with FMLP or A23187. There was a correlation between CD59 upregulation and lactoferrin release, suggesting that stores of CD59 may be associated with secondary granules. These studies indicate that PMN expression of CD59 is enhanced by cell activation and suggest the presence of an intracellular pool of CD59 which can be translocated to the cell membrane upon PMN stimulation.
Collapse
Affiliation(s)
- D L Gordon
- Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, Australia
| | | | | | | | | |
Collapse
|
32
|
|
33
|
Abstract
The technique and results of a new scalp flap that solves frontal baldness are described. As a bipediculate flap it offers a great amount of hair when advanced and has a low rate of complications. This kind of flap has been used by us for four years in 36 patients in the age group between 20 and 60 years. The results obtained with the flap have been very satisfactory.
Collapse
Affiliation(s)
- A Chajchir
- Clinica Libertador, Buenos Aires, Argentina
| | | | | |
Collapse
|
34
|
Petriz L, Arellano A, Ballester R, Galiana R, Cambray M, Arnaiz M, Gutierrez C, Pera J. Concomitant chemotherapy and radiotherapy in advanced lung cancer. A randomized study. Lung Cancer 1991. [DOI: 10.1016/0169-5002(91)91690-d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
Abstract
The results of grafts of fat obtained through liposuction are presented. They are the outcome of the current revitalization of the old technique of fat extraction and transplant. Both doctor and patient should be aware that a successful treatment is achieved through continuity. Fat grafts evolve with respect to time and permanence with reabsorption a part of the normal evolutionary process. Fat reinjection is a consequence of tissue reabsorption or a complement of the preceding injection. There is no complication associated with repeated reinjection. All cases reported here include patients with two or more reinjections, depending on their pathology and evolution.
Collapse
|
36
|
Abstract
Conjugates of fluorescein isothiocyanate with clupein YI, YII and Z, the protamines from Clupea palasii, were prepared and their fluorescence utilized to determine the rotational relaxation times of the proteins. All conjugates exhibited single component lifetimes near 4.05 ns. Linear isothermal Perrin plots were obtained for all conjugates; these data indicated rotational relaxation times of 3.33 ns for clupein YI and YII and 3.19 ns for clupein Z. These results and the results from our previous studies lead us to postulate globular conformations for the three proteins with hydrated molecular diameters of 22 A. Based on these findings a three dimensional model for Clupein YII is proposed.
Collapse
Affiliation(s)
- A Arellano
- Facultad de Ciencias, Universidad de Concepcion, Chile
| | | | | | | |
Collapse
|
37
|
Villar A, Pera J, Arellano A, Galiana R, Villá S, Farrus B, Hernandez M. Induction chemotherapy with cisplatin, bleomycin and methotrexate in advanced head and neck cancer--lack of therapeutic gain. Radiother Oncol 1987; 10:175-81. [PMID: 2448846 DOI: 10.1016/s0167-8140(87)80002-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Seventy patients with stage IV head and neck cancer were treated by two courses of induction chemotherapy followed by surgery plus postoperative irradiation (7) or radical radiotherapy (62). One patient renounced to further treatment after chemotherapy. Each chemotherapy course consisted of methotrexate (40 mg/m2 days 1 and 14), bleomycin (10 mg/m2 days 1, 7 and 14), and cisplatin (50 mg/m2 day 4). Three patients did not complete the two courses of chemotherapy planned due to bad tolerance whereas the rest of the patients tolerated chemotherapy well. 2 CR (3%) and 35 PR (50%) were achieved for an overall response rate to chemotherapy of 53%. 35 (50%) CR were achieved with the whole treatment schedule. The 5-year disease-free survival is 26% for the whole group of patients. The prior response to chemotherapy neither influenced the complete responses to treatment nor the relapse-free survival. The addition of this chemotherapy to conventional treatment was of no value.
Collapse
Affiliation(s)
- A Villar
- Servicio de Oncologia Radioterapica, Hospital Bellvitge Principes de España, Hospitalet, Barcelona, Spain
| | | | | | | | | | | | | |
Collapse
|
38
|
Villar A, Muñoz J, Aguiló F, Arellano A, Cambray M, Serrallach N. External beam irradiation for T1, T2-3 and T4 transitional cell carcinoma of the urinary bladder. Radiother Oncol 1987; 9:209-15. [PMID: 3114833 DOI: 10.1016/s0167-8140(87)80232-3] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Fifty-seven patients with T1 transitional cell carcinoma of the bladder, 57 patients with T2-3 and 10 patients with T4 were treated by radical irradiation +/- salvage cystectomy. Thirty-five patients with T1 were treated by transurethral resection (TUR) plus local chemotherapy +/- salvage cystectomy. Eleven patients with T2-3 were treated with 5 X 4 Gy in one week followed by cystectomy while four patients with T2-3 were treated with 40 Gy in 4 weeks also followed by cystectomy. Five patients with T4 were treated with 40 Gy in 4 weeks plus cystectomy. Seven year survival rates are: 69% for T1 treated by radical irradiation, 43% for T1 treated by TUR (p less than 0.02), 36% for T2-3 treated either by radical irradiation or 5 X 4 Gy plus cystectomy, and 18% for T4 treated by radical irradiation. All the survival rates indicated are free of disease and include the cases in which salvage cystectomy was successfully performed. Sixty per cent of the cured patients conserved very good functional bladders. We believe that external beam irradiation plus salvage cystectomy is indicated in the treatment of T1 and T2-3 tumours of the bladder.
Collapse
|
39
|
Calvo FA, Hornedo J, de la Torre A, Sachetti A, Arellano A, Aramburo P, Aragon G, Otero J. Intracranial tumors with risk of dissemination in neuroaxis. Int J Radiat Oncol Biol Phys 1983; 9:1297-301. [PMID: 6885542 DOI: 10.1016/0360-3016(83)90260-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
The experience of the Radiotherapy Service, Clínica Puerta de Hierro, Madrid (Spain), in the treatment of intracranial tumors with risk of neural axis dissemination is analyzed. In 15 years (1964-1979) 415 primary central nervous system tumors were studied and treated; 67 corresponded to tumors with risk of meningeal dissemination. Clinical dissemination in cerebrospinal fluid was proven in 14 patients. The actuarial survival of 10 years for patients with neural axis dissemination, without prophylactic treatment to the neuroaxis, is 14% with an average survival of 10.5 months. In approximately 20% of meduloblastomas, ependymal and pineal region tumors, meningeal metastases at some distance from the primary tumor can take place. Patients at risk wtih these types of neoplasia must be identified, and an adequate radical therapeutic focus devised, not only for the primary tumor, but also for the risk of dissemination.
Collapse
|
40
|
Abstract
Eighteen patients with cranipharyngiomas, who were studied and treated between 1970-1980, are presented. Each patient was treated with surgery and radiotherapy (50-60 Gy). Six patients were treated with radiotherapy because the tumor recurred after surgery. An extensive representation of the clinical symptomatology typical of this tumor was seen. In 3 patients an improvement in visual symptoms was demonstrated; in 11 the headaches and vomiting were controlled after treatment. The 18 treated patients are still alive without evidence of progression of the tumor, after a period of 2 to 12 years. Our experience supports the contention that conservative surgery coupled with radical radiotherapy remains the treatment of choice for the craniopharyngioma.
Collapse
|
41
|
Arellano A, Aramburo P, de la Torre A, Sachetti A, Calvo F, Aragón G, Otero J. [Treatment and prevention of lymph node metastasis of carcinomas of the oral cavity]. Rev Med Univ Navarra 1983; 27:39-43. [PMID: 6669833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
From 1964-1977, 242 previously untreated patients with a oral cavity carcinoma were treated in the Service of Radiotherapy in the Clínica Puerta de Hierro of Madrid. The actuarial survival at five years was 52,5% (26 T1, 96 T2, 120 T3). The presence of nodes in the moment of treatment was of great prognostic value. And so the actuarial survival at five years of the N(+) was 31% vs 64% in the No (p less than or equal to 005). Of 161 patients without adenopathies (No), 73 patients were treated with prophylactic irradiation of the neck, and 88 patients were kept under observation without any cervical treatment; ganglionary relapses appeared in the 5,5% of the first group vs 26% in the patients who had no cervical treatment at all (p less than or equal to 001), wich reaffirms the value of prophylactic or elective radiotherapy.
Collapse
|
42
|
Wingender E, Arellano A. Synthesis and properties of the new thiol-specific reagent difluorescein disulfide: its application on histone-histone and histone-DNA interactions. Anal Biochem 1982; 127:351-60. [PMID: 6926748 DOI: 10.1016/0003-2697(82)90186-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
43
|
Hornedo J, Calvo F, Aramburu P, Aragón G, de la Torre A, Arellano A, Otero J. [Extramedullary IgD lambda plasmacytoma mimicking a pituitary chromophobe adenoma]. Med Clin (Barc) 1982; 79:377-9. [PMID: 6816996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
44
|
|